Hostname: page-component-cb9f654ff-p5m67 Total loading time: 0 Render date: 2025-08-22T10:24:42.440Z Has data issue: false hasContentIssue false
  • English
  • Français

Do-Do Abuse

Published online by Cambridge University Press:  02 January 2018

S. Loosmore  and
D. Armstrong
S. Loosmore
Affiliation:
St David's Hospital, Carmarthen, Dyfed
D. Armstrong*
Affiliation:
Leeds Addiction Unit, 40 Clarendon Road, Leeds
*
∗ Correspondence
Get access Rights & Permissions [Opens in a new window]

Extract

Three cases of prolonged abuse of Do-Do tablets, an over-the-counter remedy for “coughs, wheezing and breathlessness”, are reported. They have an amphetamine-like action and were used as easily obtained amphetamine substitutes, in one case to relieve social anxiety. Withdrawal symptoms similar to those following cessation of amphetamines occurred in two cases. Do-Do tablets are CNS stimulants and their abuse may be accounted for by the fact that they perhaps affect amine neurotransmitters.

Information

Type
Brief Reports
Information
The British Journal of Psychiatry , Volume 157 , Issue 2 , August 1990 , pp. 278 - 281
Copyright
Copyright © Royal College of Psychiatrists, 1990 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

Anonymous (1987) Drug abuse. Pharmaceutical Journal, 239, 117.Google Scholar
Dougherty, R. J. (1982) Pseudo-speed. New York State Journal of Medicine, 1, 75–75.Google Scholar
Gilbert, R. (1988) Caffeine: the most popular stimulant. In The Encyclopedia of Psychoactive Drugs (eds S. H. Snyder & M. H. Lader). New York: Burke Publishing.Google Scholar
Griffiths, R. R. & Woodson, P. P. (1988) Reinforcing properties of caffeine: studies in humans and laboratory animals. Pharmacology, Biochemistry and Behaviour, 29, 419–427.Google Scholar
Harrison, I. (1988) The sale of medicines liable to abuse. Pharmaceutical Journal, May 7, 600.Google Scholar
Herridge, C. F. & A'Brook, M. F. (1968) Ephedrine psychosis. British Medical Journal, ii, 160.Google Scholar
Jelley, T. M. (1987) Phensedyl abuse (letter). British Journal of Psychiatry, 151, 418–419.Google Scholar
Lader, M. & Bruce, M. (1986) States of anxiety and their induction by drugs. British Journal of Clinical Pharmacology, 22, 251–261.Google Scholar
Lake, C. R. & Quirk, R. S. (1984) CNS stimulants and the look-alike drugs. Psychiatric Clinics of North America, 7, 689–701.Google Scholar
Lambert, M.T. (1987) Paranoid psychosis after abuse of proprietary cold remedies. British Journal of Psychiatry, 151, 548–550.CrossRefGoogle ScholarPubMed
Pugh, C. R. & Howie, S. M. (1986) Dependance on pseudoephedrine (letter). British Journal of Psychiatry, 149, 789.Google Scholar
Rall, T. W. (1985) Central nervous system stimulants. The methylxanthines. In The Pharmacological Basis of Therapeutics (7th edn) (eds A. G. Gilman, L. S. Goodman, T. W. Rall, et al), pp. 589–603. New York: Macmillan.Google Scholar
Siegal, R. K. (1980) Cocaine substitutes (letter). New England Journal of Medicine, 302, 817–818.Google Scholar
Whitehouse, A. M. & Duncan, J. M. (1987) Ephedrine psychosis rediscovered. British Journal of Psychiatry, 150, 258–260.Google Scholar
Williams, M. & Jarvis, M. F. (1988) Adenosine antagonists as potential therapeutic agents. Pharmacology, Biochemistry and Behaviour, 29, 433–441.CrossRefGoogle ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.